Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup

Exclusion Criteria

• •1. Symptoms or signs of any other cause of stridor;
• •2. Previous acute angioneurotic oedema;
• •3. Children with diagnosis of severe croup (Wesley score \>8);
• •4. History of congenital or acquired stridor, diagnosis of epiglottitis, chronic pulmonary disease, asthma, severe systemic disease, exposure to chickenpox virus within the previous 21 days, or known immune dysfunction;
• •5. Any other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or study drug administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the subject inappropriate for entry into this study;
• •6. Treatment with oral or parenteral corticosteroids within the previous 2 weeks; Treatment with epinephrine for respiratory distress before enrollment;
• •7. Previous visit to an emergency room department due to croup during this episode of the disease;
• •8. Inability of the parent to understand the nature and scope of the study or the possible benefits or unwanted effects of the study treatments;
• •9. Enrollment in another clinical trial in the previous 4 weeks or subject already admitted in this study
• •10. Lack of a telephone at home;